Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03064009 · ClinicalTrials.gov registry record
Regional and Seasonal Variations in the Incidence and Causative Organisms for Post-traumatic Wound Infections and Osteomyelitis After Open Fractures
A clinical trial, sponsored by University of Washington.
- Terminated
- Registry status
- 300
- Enrollment target
NCT03064009: Clinical Trial study, sponsored by University of Washington.
NCT03064009 is a clinical trial that was terminated before completion, run by University of Washington. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03064009 was terminated before completion, sponsored by University of Washington.
- TERMINATED
- Registry status
- 300 participants
- Enrollment target
Study Summary
To determine if there is a relationship between people with open fractures and the season and location of where the injury occurred and the infections they develop
Primary Outcome
Infection of the open fracture
Interventions
- OTHER Infection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2017-02-01 |
| Est. Completion | 2018-05-29 |
Why NCT03064009 stopped before completion
NCT03064009 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Infection is the first listed.
NCT03064009 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03064009 about?
NCT03064009 is a clinical study titled "Regional and Seasonal Variations in the Incidence and Causative Organisms for Post-traumatic Wound Infections and Osteomyelitis After Open Fractures". To determine if there is a relationship between people with open fractures and the season and location of where the injury occurred and the infections they develop
What is the current status of trial NCT03064009?
This trial is currently terminated. The enrollment target is 300 participants. The study started on 2017-02-01. Estimated completion is 2018-05-29.
What interventions are being tested in trial NCT03064009?
The interventions under investigation include: Infection (OTHER).
Who is sponsoring clinical trial NCT03064009?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI